About Immunoglobulin mu Fc receptor
Immunoglobulin mu Fc receptor (FCMR) is a protein
from Homo sapiens identified by UniProt accession
O60667, 390 residues long.
MolForge cross-references it against 0 known binders and
215 disease associations.
Target properties
| Protein name | Immunoglobulin mu Fc receptor |
| UniProt accession | O60667 |
| Gene | FCMR |
| Organism | Homo sapiens |
| Length | 390 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (215)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.19
- lymphocyte count · score 0.11
- common variable immunodeficiency · score 0.09
- isolated agammaglobulinemia · score 0.08
- neoplasm · score 0.08
- immunodeficiency 18 · score 0.07
- immunodeficiency 62 · score 0.07
- immunodeficiency, common variable, 4 · score 0.07
- severe combined immunodeficiency due to CTPS1 deficiency · score 0.06
- inborn error of immunity · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60667-F1 | alphafold | PREDICTED | 64.91 | — |
Amino-acid sequence (390 residues)
MDFWLWPLYF LPVSGALRIL PEVKVEGELG GSVTIKCPLP EMHVRIYLCR EMAGSGTCGT VVSTTNFIKA EYKGRVTLKQ YPRKNLFLVE VTQLTESDSG VYACGAGMNT DRGKTQKVTL NVHSEYEPSW EEQPMPETPK WFHLPYLFQM PAYASSSKFV TRVTTPAQRG KVPPVHHSSP TTQITHRPRV SRASSVAGDK PRTFLPSTTA SKISALEGLL KPQTPSYNHH TRLHRQRALD YGSQSGREGQ GFHILIPTIL GLFLLALLGL VVKRAVERRK ALSRRARRLA VRMRALESSQ RPRGSPRPRS QNNIYSACPR RARGADAAGT GEAPVPGPGA PLPPAPLQVS ESPWLHAPSL KTSCEYVSLY HQPAAMMEDS DSDDYINVPA
Explore Immunoglobulin mu Fc receptor with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets